Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas

Murakami, Y.; Saigo, K.; Takashima, H.; Minami, M.; Okanoue, T.; Bréchot, C.; Paterlini-Bréchot, P.
August 2005
Gut;Aug2005, Vol. 54 Issue 8, p1162
Academic Journal
Background and aims: Hepatitis B virus (HBV) DNA integration into or close to cellular genes is frequently detected in HBV positive hepatocellular carcinomas (HCC). We have previously shown that viral integration can lead to aberrant target gene transcription. In this study, we attempted to investigate common pathways to hepatocarcinogenesis. Methods: By using a modified Alu-polymerase chain reaction approach, we analysed 50 HCCs along with 10 previously published cases. Results: Sixty eight cellular flanking sequences (seven repetitive or unidentified sequences, 42 cellular genes, and 19 sequences potentially coding For unknown proteins) were obtained. Fifteen cancer related genes and 25 cellular genes were identified. HBV integration recurrently targeted the human telomerase reverse transcriptase gene (three cases) and genes belonging to distinct pathways: calcium signalling related genes, 60s ribosomal protein encoding genes, and platelet derived growth factor and mixed lineage leukaemia encoding genes. Two tumour suppressor genes and five genes involved in the control of apoptosis were also found at the integration site. The viral insertion site was distributed over all chromosomes except 13, X, and Y. Conclusions: In 61/68 (89.7%) cases, HBV DNA was integrated into cellular genes potentially providing cell growth advantage. Identification of recurrent viral integration sites into genes of the same family allows recognition of common cell signalling pathways activated in hepatocarcinogenesis.


Related Articles

  • Hepatitis B virus X gene and hepatocarcinogenesis. Ng, Sue-Ann; Lee, Caroline // Journal of Gastroenterology;Aug2011, Vol. 46 Issue 8, p974 

    Chronic hepatitis B virus (HBV) infection has been identified as a major risk factor in hepatocellular carcinoma (HCC), which is one of the most common cancers worldwide. The pathogenesis of HBV-mediated hepatocarcinogenesis is, however, incompletely understood. Evidence suggests that the HBV X...

  • The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver. Terradillos, Olivier; La Coste, Alix de; Pollicino, Teresa; Neuveut, Christine; Sitterlin, Delphine; Lecour, Herve; Gougeon, Marie-Lise; Kahn, Axel; Buendia, Marie-Annick // Oncogene;1/17/2002, Vol. 21 Issue 3, p377 

    Presents a study that examined whether the proapoptotic function of HBx, a regulatory protein encoded by hepatitis B virus (HBV) genome, can interfere with Bcl-2 during hepatic apoptosis. Finding on the apoptosis induced by ectopic expression of HBx; Nature of HBV; Role of HBV in th...

  • Hepatitis B virus core protein inhibits TRAIL-induced apoptosis of hepatocytes by blocking DR5 expression. J. Du; X. Liang; Y. Liu; Z. Qu; L. Gao; L. Han; S. Liu; M. Cui; Y. Shi; Z. Zhang; L. Yu; L. Cao; C. Ma; L. Zhang; Y. Chen; W. Sun // Cell Death & Differentiation;Feb2009, Vol. 16 Issue 2, p219 

    Hepatitis B virus (HBV) causes chronic hepatitis in hundreds of millions of people worldwide, which can eventually lead to hepatocellular carcinoma (HCC). The molecular mechanisms underlying HBV persistence are not well understood. TRAIL, the TNF-related apoptosis-inducing ligand, has recently...

  • Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis. Huo, Teh-Ia; Wang, Xin W; Forgues, Marshonna; Wu, Chuan-Ging; Spillare, Elisa A; Giannini, Carlo; Brechot, Christian; Harris, Curtis C // Oncogene;6/21/2001, Vol. 20 Issue 28, p3620 

    Chronic hepatitis B virus (HBV) infection and the integration of its X gene (HBx) are closely associated with the development of hepatocellular carcinoma (HCC). The integrated HBx frequently is truncated or contains point mutations. Previous studies indicated that these HBx mutants have a...

  • A Case of Juvenile Hepatocellular Carcinoma Associated with Liver Cirrhosis in a Family Clustering of HBs Antigen Carriers and Liver Diseases. Nunoda, Shin-ichi; Mimo, Naonori; Kitano, Hirotsugu; Kyo, Masanori; Hifumi, Senshu; Ueno, Toshio; Takeda, Ryoyu; Nakanuma, Yasuni // American Journal of Gastroenterology;May1983, Vol. 78 Issue 5, p301 

    We describe a case of hepatocellular carcinoma in a 16-year-old boy whose mother, aunts, uncles, and cousins had liver dysfunction associated with HBs-Ag. Postmortem examination in this case revealed a hepatocellular carcinoma with a trabecular and partially pseudoglandular pattern involving the...

  • Genome-Wide Association Study of Hepatocellular Carcinoma in Southern Chinese Patients with Chronic Hepatitis B Virus Infection. Kelvin Yuen-Kwong Chan; Chun-Ming Wong; Johnny Sheung-Him Kwan; Joyce Man-Fong Lee; Ka Wai Cheung; Man Fung Yuen; Ching Lung Lai; Ronnie Tung-Ping Poon; Pak Chung Sham; Irene Oi-Lin Ng // PLoS ONE;2011, Vol. 6 Issue 12, p1 

    One of the most relevant risk factors for hepatocellular carcinoma (HCC) development is chronic hepatitis B virus (HBV) infection, but only a fraction of chronic HBV carriers develop HCC, indicating that complex interactions among viral, environmental and genetic factors lead to HCC in...

  • Antiviral Therapy for Chronic Hepatitis B: A Review. Hanazaki, Kazuhiro // Current Drug Targets - Inflammation & Allergy;Mar2004, Vol. 3 Issue 1, p63 

    Chronic hepatitis B virus (HBV) infection is a well-recognized risk factor for the development of hepatocellular carcinoma (HCC), which is becoming a more prevalent clinical problem, especially in HBV-endemic areas. It is estimated that 1.25 million people in the United States and more than 300...

  • Hepatitis B virus regulation of Raf1 promoter activity through activation of transcription factor AP-2α. Qu, Jialin; Li, Jianbo; Chen, Ke; Qin, Dongdong; Li, Kai; Sheng, Yanrui; Zou, Chengcheng; Wang, Sen; Huang, Ailong; Tang, Hua // Archives of Virology;Apr2013, Vol. 158 Issue 4, p887 

    The X protein of hepatitis B virus (HBx) is one of the important factors in the development of hepatocellular carcinoma. Raf1 kinase is a central component of many signaling pathways that are involved in normal cell growth and oncogenic transformation. We previously demonstrated that hepatitis B...

  • The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1. Tanaka, Y.; Kanai, F.; Ichimura, T.; Tateishi, K.; Asaoka, Y.; Guleng, B.; Jazag, A.; Ohta, M.; Imamura, J.; Ikenoue, T.; Ijichi, H.; Kawabe, T.; Isobe, T.; Omata, M. // Oncogene;1/26/2006, Vol. 25 Issue 4, p633 

    Hepatitis B virus X protein (HBx) has many cellular functions and is a major factor in hepatitis and hepatocellular carcinoma caused by HBV infection. A proteomic approach was used to search for HBx-interacting proteins in order to elucidate the molecular mechanism of hepatocarcinogenesis. HBx...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics